Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.2.0.727
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2015
Dec. 31, 2014
Current assets:    
Cash and cash equivalents [note 4] $ 48,001 $ 27,897
Restricted cash [note 4]   251
Short-term investments [note 4] 12,185 19,160
Interest receivable 76 113
Amounts receivable 149 5,676
Prepaid expenses 2,032 2,165
Other current assets 304 499
Total current assets 62,747 55,761
Restricted cash [note 4] 190  
Property and equipment, net 406 257
Other assets 13 273
Total assets 63,356 56,291
Current liabilities:    
Accounts payable 302 72
Accrued liabilities other 954 863
Accrued clinical liabilities 10,478 13,462
Accrued compensation 1,252 1,333
Current portion of long-term obligations [note 6 and 7] 54 236
Lease termination liability [note 6 and note 7] 1,250 3,250
Deferred collaboration revenue [note 3] 17,778  
Warrant liability [note 4 and note 5] 2,967 3,002
Total current liabilities 35,035 22,218
Long-term obligations, less current portion [note 7] 130 14
Total liabilities $ 35,165 $ 22,232
Commitments and contingencies [note 7]    
Stockholders' equity:    
Common stock, $0.001 par value, 75,000,000 shares authorized, 24,467,727 and 22,630,652 issued at June 30, 2015 and December 31, 2014, respectively, and 24,433,734 and 22,621,426 outstanding at June 30, 2015 and December 31, 2014, respectively $ 24 $ 22
Additional paid-in capital 196,067 191,373
Accumulated deficit (170,537) (159,958)
Accumulated other comprehensive income 2,637 2,622
Total stockholders' equity 28,191 34,059
Total liabilities and stockholders' equity $ 63,356 $ 56,291